innoscripta SE receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
innoscripta SE (1INN)
innoscripta SE stock price live, this page displays ETR 1INN stock exchange data. View the 1INN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the innoscripta SE real time stock price chart below.
What Is the innoscripta SE Stock Price Today?
The innoscripta SE stock price today is 45.25.
What Is the Stock Symbol for innoscripta SE?
The stock ticker symbol for innoscripta SE is 1INN.
Is 1INN the Same as $1INN?
$1INN is a common way to refer to the innoscripta SE ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does innoscripta SE Trade On?
innoscripta SE is listed and trades on the Xetra stock exchange.
Is innoscripta SE a Good Stock to Buy?
Determining whether innoscripta SE—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current innoscripta SE share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1INN quote. (ISIN: DE000A40QVM8)
What Is the innoscripta SE Stock Price Today?
The innoscripta SE stock price today is 45.25.
What Is the Stock Symbol for innoscripta SE?
The stock ticker symbol for innoscripta SE is 1INN.
Is 1INN the Same as $1INN?
$1INN is a common way to refer to the innoscripta SE ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does innoscripta SE Trade On?
innoscripta SE is listed and trades on the Xetra stock exchange.
Is innoscripta SE a Good Stock to Buy?
Determining whether innoscripta SE—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current innoscripta SE share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1INN quote. (ISIN: DE000A40QVM8)
45.25
-0.45(-0.98%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.20
46.55
52 wk Range
31.10
114.00
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.2046.55
52 wk Range
31.10114.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1INN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
207.67
Upside
+358.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Innoscripta SE receives Investment Bank Analyst Rating Update- Investing.com
Pro
- innoscripta SE receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Innoscripta SE receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 207.67
(+358.94% Upside)
innoscripta SE Earnings Call Summary for Q2/2026
- H1 2026 revenue rose 43% to EUR 63M; EBIT up 49% to EUR 36.4M, but shares fell 9% on software migration delays pushing revenue to later quarters.
- Management reaffirmed full-year 2026 guidance of EUR 140M revenue and EUR 80M EBIT despite temporary timing effects from Q1 system migration.
- Stock dropped to $75 from $82.40, now 45% below 52-week high of $137; InvestingPro analysis suggests shares undervalued at current P/E of 20.3.
- Company expanding into France, U.S., and U.K. markets but expects no material 2026 revenue contribution; targets $1M revenue per market within 12 months.
- German core business remains strong with sub-2% churn, 2,900 customers, and 10% penetration of R&D workforce; 31% of large enterprises are clients.
Last Updated: 08/25/2026, 10:53 AM
Read Full Transcriptinnoscripta SE investor slides for Q2/2026
Last Update: Aug 25, 2026
See full investor slides
Earnings
Latest Release
Aug 25, 2026
EPS / Forecast
0.63 / --
Revenue / Forecast
22.9M / --
Compare 1INN to Peers and Sector
Metrics to compare | 1INN | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship Relationship1INNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 8.9x | 26.7x | 10.5x | |
PEG Ratio | 0.17 | 1.39 | 0.01 | |
Price / Book | 11.9x | 5.1x | 2.4x | |
Price / LTM Sales | 3.7x | 3.9x | 2.0x | |
Upside (Analyst Target) | 346.0% | 35.4% | 54.3% | |
Fair Value Upside | Unlock | 21.6% | 13.0% | Unlock |
innoscripta SE provides software-as-a-service for managing research and development (R&D) tax incentives and project management consulting in European markets, including Germany, France, Romania, Denmark, Finland, Switzerland, Spain, Portugal, Slovakia, the Netherlands, and the United Kingdom. It offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable. It offers solutions for research and development documentation, such as human resources, task management, organization, project management, and time tracking. It serves the additive manufacturing/3D printing; aerospace engineering; automotive; biotechnology; business consulting and technical services; chemical; construction; electrical engineering; energy; environmental technology and circular economy financial services/fintech; food and beverage; IT and software development; metal working; medical technology; mechanical engineering; manufacturing for industry; logistics; optical engineering and photonics; pharmaceutical; retail; research and development; textile industry/technical textiles; and professional, scientific, and technical services industries. The company was incorporated in 2012 and is headquartered in Munich, Germany. innoscripta SE operates as a subsidiary of Hohenester Beteiligungs-Ug (Haftungsbeschränkt).
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the innoscripta SE (1INN) Stock Price Today?
The innoscripta SE stock price today is 45.25 EUR.
What Stock Exchange Does innoscripta SE Trade On?
innoscripta SE is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for innoscripta SE?
The stock symbol for innoscripta SE is "1INN."
Does innoscripta SE Pay Dividends? What’s The Current Dividend Yield?
The innoscripta SE dividend yield is 8.8%%.
What Is the innoscripta SE Market Cap?
As of today, innoscripta SE market cap is 457.00M EUR.
What Is innoscripta SE's Earnings Per Share (TTM)?
The innoscripta SE EPS (TTM) is 5.13.
When Is the Next innoscripta SE Earnings Date?
innoscripta SE will release its next earnings report on Dec 02, 2026.
From a Technical Analysis Perspective, Is 1INN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has innoscripta SE Stock Split?
innoscripta SE has split 0 times.
How Many Employees Does innoscripta SE Have?
innoscripta SE has 396 employees.
What is the current trading status of innoscripta SE (1INN)?
As of Nov 10, 2026, innoscripta SE (1INN) is trading at a price of 45.25 EUR, with a previous close of 45.70 EUR. The stock has fluctuated within a day range of 45.20 EUR to 46.55 EUR, while its 52-week range spans from 31.10 EUR to 114.00 EUR.
What Is innoscripta SE (1INN) Price Target According to Analysts?
The average 12-month price target for innoscripta SE is 207.67 EUR, with a high estimate of 207.66813859 EUR and a low estimate of 207.66813859 EUR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +358.94% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.